Literature DB >> 7458907

The interrelations between high- and low-molecular weight forms of normal and mutant (Krabbe-disease) galactocerebrosidase.

Y Ben-Yoseph, M Hungerford, H L Nadler.   

Abstract

Galactocerebrosidase (beta-d-galactosyl-N-acylsphingosine galactohydrolase; EC 3.2.1.46) activity of brain and liver preparations from normal individuals and patients with Krabbe disease (globoid-cell leukodystrophy) have been separated by gel filtration into four different molecular-weight forms. The apparent mol.wts. were 760000+/-34000 and 121000+/-10000 for the high- and low-molecular-weight forms (peaks I and IV respectively) and 499000+/-22000 (mean+/-s.d.) and 256000+/-12000 for the intermediate forms (peaks II and III respectively). On examination by sodium dodecyl sulphate/polyacrylamide-gel electrophoresis, the high- and low-molecular-weight forms revealed a single protein band with a similar mobility corresponding to a mol.wt. of about 125000. Antigenic identity was demonstrated between the various molecular-weight forms of the normal and the mutant galactocerebrosidases by using antisera against either the high- or the low-molecular-weight enzymes. The high-molecular-weight form of galactocerebrosidase was found to possess higher specific activity toward natural substrates when compared with the low-molecular-weight form. It is suggested that the high-molecular-weight enzyme is the active form in vivo and an aggregation process that proceeds from a monomer (mol.wt. approx. 125000) to a dimer (mol.wt. approx. 250000) and from the dimer to either a tetramer (mol.wt. approx. 500000) or a hexamer (mol.wt. approx. 750000) takes place in normal as well as in Krabbe-disease tissues.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7458907      PMCID: PMC1161912          DOI: 10.1042/bj1890009

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  30 in total

1.  A simple chromatographic method for preparation of gamma globulin.

Authors:  H B LEVY; H A SOBER
Journal:  Proc Soc Exp Biol Med       Date:  1960-01

2.  Effects of de-icing salt on ground water characteristics.

Authors:  J E O'Brien; J C Majewski
Journal:  Environ Lett       Date:  1975

3.  A simple procedure for removal of Triton X-100 from protein samples.

Authors:  P W Holloway
Journal:  Anal Biochem       Date:  1973-05       Impact factor: 3.365

4.  Stimulation of acid beta-galactosidase activity by chloride ions.

Authors:  M W Ho; J S O'Brien
Journal:  Clin Chim Acta       Date:  1970-11       Impact factor: 3.786

5.  The separation and characterization of the methylumbelliferyl beta-galactosidases of human liver.

Authors:  P S Cheetham; N E Dance
Journal:  Biochem J       Date:  1976-07-01       Impact factor: 3.857

6.  Lactosylceramide beta-galactosidase in human sphingolipidoses. Evidence for two genetically distinct enzymes.

Authors:  H Tanaka; K Suzuki
Journal:  J Biol Chem       Date:  1975-03-25       Impact factor: 5.157

7.  Globoid cell leucodystrophy (Krabbe's disease): deficiency of galactocerebroside beta-galactosidase.

Authors:  K Suzuki; Y Suzuki
Journal:  Proc Natl Acad Sci U S A       Date:  1970-06       Impact factor: 11.205

8.  Quantitation of the enzymically deficient cross reacting material in GM1 gangliosidoses.

Authors:  Y Ben-Yoseph; B K Burton; H L Nadler
Journal:  Am J Hum Genet       Date:  1977-11       Impact factor: 11.025

9.  Globoid cell leukodystrophy: additional deficiency of psychosine galactosidase.

Authors:  T Miyatake; K Suzuki
Journal:  Biochem Biophys Res Commun       Date:  1972-08-07       Impact factor: 3.575

10.  Cerebroside galactosidase of brain.

Authors:  A K Hajra; D M Bowen; Y Kishimoto; N S Radin
Journal:  J Lipid Res       Date:  1966-05       Impact factor: 5.922

View more
  1 in total

1.  Self-association of human beta-galactocerebrosidase: Dependence on pH, salt, and surfactant.

Authors:  Eunhee Lee; Nazila Salamat-Miller; Walter F Stafford; Katherine Taylor
Journal:  PLoS One       Date:  2019-12-23       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.